02/28/2024 11:15 PM | MEI Pharma (Filer)
| Form EFFECT | |
02/28/2024 3:04 PM | MEI Pharma (Filer)
| Form 424B5 | |
02/20/2024 4:33 PM | MEI Pharma (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
01/12/2024 3:00 PM | MEI Pharma (Issuer) Wood Steven D (Reporting)
| Form 4/A | |
01/12/2024 3:00 PM | Flynn James P (Reporting) MEI Pharma (Issuer)
| Form 4/A | |
12/26/2023 4:00 PM | MEI Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/22/2023 3:00 PM | MEI Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
12/20/2023 8:26 PM | MEI Pharma (Issuer) Wood Steven D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 8:25 PM | Flynn James P (Reporting) MEI Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/14/2023 7:59 PM | MEI Pharma (Issuer) Wood Steven D (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/09/2023 3:00 PM | MEI Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/08/2023 4:03 PM | MEI Pharma (Filer)
| Form DEFA14A | |
11/08/2023 4:04 PM | MEI Pharma (Filer)
| Form ARS | |
11/06/2023 4:06 PM | Datoo Taheer (Reporting) MEI Pharma (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
11/03/2023 5:04 PM | Flynn James P (Reporting) MEI Pharma (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
11/01/2023 4:15 PM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form DFAN14A | |
11/01/2023 4:20 PM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form SC 13D/A | |
11/01/2023 3:54 PM | MEI Pharma (Filer)
| Form DEFA14A | |
10/24/2023 6:32 PM | Anson Advisors Inc. (Reporting) Anson Funds Management LP (Reporting) Anson Management GP LLC (Reporting) Kassam Moez (Reporting) MEI Pharma (Issuer) Nathoo Amin (Reporting) Winson Bruce Ross (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/24/2023 6:34 PM | Cable Car Capital LLC (Reporting) Funicular Funds, LP (Reporting) Ma-Weaver Jacob (Reporting) MEI Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/24/2023 4:00 PM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form SC 13D/A | |
10/17/2023 4:28 PM | MEI Pharma (Subject)
| Form DEFC14A | |
10/13/2023 4:00 PM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form SC 13D/A | |
10/13/2023 4:02 PM | Anson Advisors Inc. (Reporting) Anson Funds Management LP (Reporting) Anson Management GP LLC (Reporting) Kassam Moez (Reporting) MEI Pharma (Issuer) Nathoo Amin (Reporting) Winson Bruce Ross (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/13/2023 4:04 PM | Cable Car Capital LLC (Reporting) Funicular Funds, LP (Reporting) Ma-Weaver Jacob (Reporting) MEI Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/12/2023 6:38 PM | GHALIE RICHARD G (Reporting) MEI Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/12/2023 6:39 PM | KANGO SUJAY (Reporting) MEI Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/12/2023 6:40 PM | MEI Pharma (Issuer) Reynolds Thomas C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/12/2023 6:40 PM | HOWSON TAMAR D (Reporting) MEI Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/12/2023 6:41 PM | GOLD DANIEL P PHD (Reporting) MEI Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/12/2023 6:41 PM | Glover Nicholas (Reporting) MEI Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/12/2023 6:41 PM | DRISCOLL FREDERICK W (Reporting) MEI Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/12/2023 6:42 PM | Baltic Charles V. III (Reporting) MEI Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/12/2023 4:25 PM | MEI Pharma (Filer)
| Form PRER14A | |
10/10/2023 2:00 PM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form DFAN14A | |
10/10/2023 9:33 AM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form DEFC14A | |
10/03/2023 5:33 AM | MEI Pharma (Filer)
| Form 8-A12B | |
10/03/2023 5:04 AM | MEI Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/02/2023 4:27 PM | MEI Pharma (Filer)
| Form DEFA14A | |
10/02/2023 7:42 AM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form PREC14A | |
09/29/2023 4:13 PM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form DFAN14A | |
Your $200 account credit is about to expire (Ad) Update to MarketBeat All Access and Save $200 on Your Annual Subscription. Start Your Risk-Free Trial Here |
09/28/2023 4:17 PM | MEI Pharma (Filer)
| Form DEFA14A | |
09/26/2023 4:19 PM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form SC 13D/A | |
09/26/2023 4:21 PM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form DFAN14A | |
09/26/2023 3:31 PM | MEI Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/26/2023 3:11 PM | MEI Pharma (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
09/26/2023 2:42 PM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form DEFC14A | |
09/25/2023 6:41 PM | Cable Car Capital LLC (Reporting) Funicular Funds, LP (Reporting) Ma-Weaver Jacob (Reporting) MEI Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/25/2023 6:43 PM | Anson Advisors Inc. (Reporting) Anson Funds Management LP (Reporting) Anson Management GP LLC (Reporting) Kassam Moez (Reporting) MEI Pharma (Issuer) Nathoo Amin (Reporting) Winson Bruce Ross (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/22/2023 8:19 PM | Cable Car Capital LLC (Reporting) Funicular Funds, LP (Reporting) Ma-Weaver Jacob (Reporting) MEI Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/22/2023 8:21 PM | Anson Advisors Inc. (Reporting) Anson Funds Management LP (Reporting) Anson Management GP LLC (Reporting) Kassam Moez (Reporting) MEI Pharma (Issuer) Nathoo Amin (Reporting) Winson Bruce Ross (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/22/2023 4:21 PM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form SC 13D/A | |
09/22/2023 4:24 PM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form DFAN14A | |
09/21/2023 7:12 PM | Klarquist Scott (Filed by) MEI Pharma (Subject)
| Form PX14A6G | |
09/18/2023 3:16 PM | MEI Pharma (Filer)
| Form DEFA14A | |
09/18/2023 8:29 AM | MEI Pharma (Subject)
| Form PREC14A | |
09/15/2023 4:29 PM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form SC 13D/A | |
08/04/2023 4:15 PM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form PRRN14A | |
08/01/2023 6:07 PM | File Justin J. (Reporting) MEI Pharma (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
07/27/2023 4:27 PM | MEI Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/24/2023 8:16 AM | MEI Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/19/2023 3:35 PM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form DFAN14A | |
07/18/2023 4:26 PM | MEI Pharma (Subject)
| Form 425 | |
07/18/2023 4:20 PM | MEI Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/17/2023 3:34 PM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form SC 13D/A | |
07/17/2023 3:34 PM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form DFAN14A | |
07/17/2023 3:02 PM | MEI Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/17/2023 3:03 PM | MEI Pharma (Subject)
| Form 425 | |
07/17/2023 8:15 AM | Anson Funds Management LP (Filed by) MEI Pharma (Subject)
| Form PREC14A | |
07/13/2023 3:19 PM | MEI Pharma (Filer)
| Form 424B3 | |
07/13/2023 3:15 PM | MEI Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/13/2023 3:17 PM | MEI Pharma (Subject)
| Form 425 | |
07/10/2023 8:10 AM | Klarquist Scott (Filed by) MEI Pharma (Subject)
| Form PX14A6G | |
07/07/2023 3:51 PM | MEI Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/03/2023 3:56 PM | MEI Pharma (Filer)
| Form 424B3 | |
06/28/2023 5:07 AM | MEI Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/28/2023 5:09 AM | MEI Pharma (Subject)
| Form 425 | |
06/20/2023 5:11 AM | MEI Pharma (Subject)
| Form 425 | |
06/20/2023 5:08 AM | MEI Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/13/2023 8:28 PM | MEI Pharma (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/13/2023 3:01 PM | MEI Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/13/2023 3:10 PM | MEI Pharma (Subject)
| Form 425 | |
06/06/2023 11:15 PM | MEI Pharma (Filer)
| Form EFFECT | |
06/06/2023 3:37 PM | MEI Pharma (Issuer) Urso David M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2023 7:54 PM | MEI Pharma (Filer)
| Form S-4/A | |
06/02/2023 7:15 AM | MEI Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/02/2023 7:20 AM | MEI Pharma (Subject)
| Form 425 | |
06/01/2023 7:16 AM | MEI Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/01/2023 7:22 AM | MEI Pharma (Filer)
| Form DEFA14A | |
05/30/2023 8:00 PM | MEI Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/30/2023 8:02 PM | MEI Pharma (Filer)
| Form DEFA14A | |
weirdest stock market marches on (Ad) For the last few months, Graham Lindman has been urging investors to ignore virtually every stock on the exchange and only focus on the handful of “Apex Stocks” that produce all the wealth.
And he sure seems to be right!
Because while we’re in an extremely bullish market, it’s not because most companies are doing that well. It’s because a handful of wealth generating juggernauts are yanking the market to all time highs.
That’s why this headline called it the “Weirdest bull market” Graham is hosting a “tell all” workshop about his Apex Indicator here |
05/30/2023 8:44 PM | Anson Advisors Inc. (Reporting) Anson Funds Management LP (Reporting) Anson Management GP LLC (Reporting) Kassam Moez (Reporting) MEI Pharma (Issuer) Nathoo Amin (Reporting) Winson Bruce Ross (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
05/30/2023 7:25 PM | Cable Car Capital LLC (Reporting) Funicular Funds, LP (Reporting) Ma-Weaver Jacob (Reporting) MEI Pharma (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |